Sign up to save your podcasts
Or
Share Cost of new Alzheimer's drug could put it out of reach for many in Australia
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Cost of new Alzheimer's drug could put it out of reach for many in Australia
The development of the first drug in 30 years that modifies the disease - and not just the symptoms - of the most common form of dementia has given hope to patients. The drug Lecanemab is now undergoing a regulatory approval process in Australia and other countries in the world, but its exorbitant cost means few will be able to access it.
View all episodes
By SBSThe development of the first drug in 30 years that modifies the disease - and not just the symptoms - of the most common form of dementia has given hope to patients. The drug Lecanemab is now undergoing a regulatory approval process in Australia and other countries in the world, but its exorbitant cost means few will be able to access it.